Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race
Introduction
Diabetes is one of the most common chronic diseases, affecting 30 million people in the United States, with Type 2 diabetes mellitus (hereinafter referred to as diabetes) being the most common [1]. Its prevalence increases every year [2] and over the past two decades has reached epidemic proportions, being a major cause of morbidity and mortality in the United States [3], [4]. Many studies describe disparities in diabetes prevalence, incidence, and mortality among different race and ethnicity groups, with increased rates observed in racial and ethnic minority groups [5], [6], [7], [8]. While disparities due to diabetes alone are well-described, less understood are disparities related to other chronic conditions associated with diabetes, including combinations of these comorbidities. Using claims data from a cohort of Medicare beneficiaries in the State of Michigan, the aims of this study are three-fold:
- 1.
Confirm disparities in diabetes mortality rates based on race;
- 2.
Determine if race is predictive of combinations of diabetes and multiple chronic conditions (MCC) that are leading causes of death (LCD); and
- 3.
Determine if combinations of diabetes plus MCC mediate the relationship between race and mortality.
Several studies provide evidence that racial and ethnic minorities experience diabetes-related mortality at higher rates compared to whites. For instance, Golden et al. [9] found that Black, Native Americans and Alaskan Natives, and Hispanics exhibit 2.3, 1.9, and 1.5 times greater mortality related to diabetes, respectively, than their White counterparts. Other studies [10], [11], [12] report similar increases in mortality among Blacks explained by economic inequality and segregation [10], as well as socioeconomic status [11]. These studies suggest that access to health care, which is a key disadvantage for minority populations, does not solely account for the increased diabetes-only mortality rates among racial and ethnic minorities. However, a review of the literature shows an incomplete understanding of the relationship between race/ethnicity and diabetes-only mortality, especially when accounting for various confounding factors that could contribute to such disparities.
Diabetes is comorbid with MCC that are LCD in the United States, including cardiovascular disease (CVD), chronic kidney disease (CKD), cancer, chronic obstructive pulmonary disease (COPD), Alzheimer’s disease (AD), and stroke [13]. Certain combinations of diabetes and chronic conditions, such as diabetes and CHF, or diabetes and CKD, have been well studied, and thus there is extensive literature on racial and ethnic disparities in the development of these chronic conditions in patients with diabetes. Racial and ethnic minorities, particularly Hispanics and Blacks, exhibit increased rates of diabetes-related CKD compared to Whites [9], [14]. In addition, Hispanics and African Americans with diabetes have a higher prevalence of early CKD compared to Whites, with some evidence that Blacks experience a more rapid decline in renal function compared to Whites once they develop proteinuria [15], [16].
While racial and ethnic minorities experience greater rates of CKD with diabetes, the combination of diabetes and congestive heart failure (CHF) is more prevalent in Whites. Whites with diabetes are more likely to develop CHF or other cardiovascular complications compared to racial and ethnic minority populations [14], as one study demonstrated that increasing levels of HbA1c, used as a measure of progressing diabetes, increased the risk of developing CHF in Whites compared to racial and ethnic minorities [17]. Wong et al. [18] reported that Hispanic and Black populations with diabetes are at lower risk of developing cardiovascular disease than Whites with diabetes.
The risks of comorbid cancer, COPD, Stroke and AD are less well described. A few studies report that Blacks and Hispanics with diabetes are at increased risk for liver or colorectal cancer [19], [20], [21], while breast cancer is not more prevalent in any racial or ethnic subgroup [22]. A systematic review by Gläser et al. [23] found that diabetes can worsen the progression and prognosis of COPD, while Davis et al. [24] reported that among adults aged 60–79, Blacks had twice the prevalence of diabetes plus COPD as other racial and ethnic populations. Data regarding stroke in combination with diabetes is not well described, with some studies reporting higher rates of stroke among Blacks and Hispanics, but they leave open the possibility that this could be due to minority populations exhibiting higher rates of stroke and diabetes in general [5], [25], [26]. Another study found that racial and ethnic minority populations were at lower risk of developing all forms of diabetic cardiovascular disease, including stroke [27]. Finally, there is an even larger gap in the understanding of the relationship between diabetes and AD. One study demonstrates that uncontrolled diabetes increases the risk of AD, however it did not discuss racial or ethnic disparities related to risk [28]. Another study demonstrated that diabetes led to increases in cognitive decline in old age, but there was no difference in cognitive decline between Blacks and Whites [29].
The literature summarized here describes disparities between racial and ethnic groups in the context of the relationship between diabetes and individual chronic conditions. However, little is known about disparities between racial and ethnic groups in diabetes plus MCC (i.e. more than one additional chronic condition). One study found that minority diabetic patients are more likely to be diagnosed with end-stage diabetic nephropathy, but they have fewer other conditions such as CVD, COPD and cancer [30]. Young et al. [30] found that the risk of CVD-related mortality in non-Hispanic whites with diabetes was higher than that of minorities. Davis et al. [24] reported that the co-occurrence of diabetes, CVD and cancer amongst Hispanics, non-Hispanic blacks and Whites increased with age; however, non-Hispanic Whites had lower prevalence of these comorbidities compared to minorities.
Little research exists that focuses on the relationship between diabetes and multiple chronic conditions and mortality. Individuals with diabetes have an increased risk of developing other chronic conditions, and vice versa, that can lead to death at a more rapid rate than those without these conditions [31], [32]. Determining whether there is a racial component and how other factors affect diabetes-related mortality is essential for a more complete understanding of diabetes-related mortality. Using Medicare claims data for Michigan beneficiaries with Type 2 diabetes mellitus, we aim to determine if race and various demographic characteristics influence mortality and combinations of diabetes and various chronic conditions, and whether the presence of multiple chronic conditions mediates the relationship between race/ethnicity and mortality (see Fig. 1 for our conceptual model).
Section snippets
Data
We used 2012 claims data from the Centers for Medicare and Medicaid Services (CMS) for all Medicare beneficiaries in the State of Michigan. The Master Beneficiary Segment Files (MBSF) include four separate databases. The Base Segment database provides basic beneficiary demographic information. The Chronic Conditions Warehouse (CCW) database includes variables that code for the presence of any of 27 chronic conditions tracked by CMS. The Cost and Use database provides information about total
Results
Table 1 includes descriptive statistics for our entire sample as well as the mortality rates per 1000 person-years. The average age of our sample is 77.2 years old, and consistent with this age group and U.S. census data, our sample is mostly female (56.1%) and mostly white (82.0%). A little over 89% live in counties designated as urban, and about 18% received some Part D subsidy during the year, indicating incomes low enough to meet the requirements for receiving the subsidy. Close to 65% of
Discussion
The aim of this study was to determine if there are differences in mortality rates, and combinations of diabetes and MCC, based on race and other socio-demographics among Medicare beneficiaries in the state of Michigan with diabetes and other chronic conditions. Our results indicate that race does influence overall mortality in this cohort. Contrary to other literature [36], [37], we observed lower risk (A/PIs) or no difference in risk (Hispanics) of all-cause mortality compared to Whites. In
Acknowledgements
Funding: This work was supported by the National Institutes of Health [Grant number: 1R15DK104260-01A1, 2015-2019].
Author contributions
JC obtained and managed data, led statistical analysis, wrote/reviewed/edited the manuscript, and approved the final manuscript; BW. Managed data, conducted statistical analysis, wrote/reviewed/edited the manuscript, and approved the final manuscript; ZY, BL, DM, JH, MT, and GE contributed to the literature review/introduction, interpretation of results, and discussion, and approved the final manuscript.
Declaration of Competing Interest
The authors have no conflicts of interest to disclose.
References (43)
- et al.
Stemming the tide: rising prevalence and ethnic subgroup variation among Asians in Los Angeles County
Prev Med
(2014) - et al.
Risk of mortality associated to chronic kidney disease in patients with type 2 diabetes mellitus: a 13-year follow-up
Nefrologia
(2015) - et al.
Did Medicare Part D reduce mortality?
J Health Econ
(2017) - American Diabetes Association [Internet]. Statistics about diabetes. Available from:...
- et al.
Diabetes trends in the USA
Diabetes Metab Res Rev
(2002) - et al.
Epidemiology of diabetes and diabetes-related complications
Phys Ther
(2008) - et al.
Global and societal implications of the diabetes epidemic
Nature
(2001) - et al.
Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012
JAMA
(2014) - et al.
Associations between race, lifecourse socioeconomic position and prevalence of diabetes among US women and men: results from a population-based panel study
J Epi Community Health
(2014) - et al.
Prevalence of and trends in diabetes among adults in the United States, 1988–2012
JAMA
(2015)
Health disparities in endocrine disorders: Biological, clinical, and nonclinical factors – an Endocrine Society scientific statement
J Clin Endocrinol Metab
Racial disparities in diabetes mortality in the 50 most populous US cities
J Urban Health
Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review
Diabetes Care
Mortality disparities in racial/ethnic minority groups in the Veterans Health Administration: an evidence review and map
Am J Public Health
Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes—2018
Diabetes Care
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Am Heart J
Progression of chronic kidney disease in a multi-ethnic community cohort of patients with diabetes mellitus
Diabetic Med: J Brit Diabetic Assoc
Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease
Diabetes Care
HbA1c and coronary heart disease risk among diabetic patients
Diabetes Care
Global cardiovascular disease risk assessment in United States adults with diabetes
Diab Vasc Dis Res
Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status
Cancer Causes Control
Cited by (38)
Social determinants predict whether Medicare beneficiaries are offered a Comprehensive Medication Review
2023, Research in Social and Administrative PharmacyCitation Excerpt :Previous research has shown social determinants of health are associated with CMR completion.15,16 Race continues to be associated with worse health outcomes, especially for African American and North American Native beneficiaries with multiple chronic conditions, one of the eligibility criteria for MTM.17 The LIS program of Medicare Part D was established for low income beneficiaries and includes those who are DE.18
Chronic Kidney Disease Burden in Low-Resource Settings: Regional Perspectives
2022, Seminars in NephrologyRacial disparities in symptomatology and outcomes of COVID-19 among adults of Arkansas
2022, Preventive Medicine ReportsCitation Excerpt :Likewise, among patients with COVID-19 from a large Midwestern academic health system, NH-black race was associated with COVID-19 test positivity, and both race and low poverty level was associated with higher risk of hospitalization. ( Muñoz-Price et al., 2020) Increased burden of comorbidity among NH-blacks (Clements, 2020) placed them at higher risk for adverse COVID-19 outcomes. ( Wiley et al., 2022).
Association between mental health outcomes and lifetime criminal justice involvement in U.S. adults with diabetes
2022, Journal of Affective DisordersMental Health Issues During and After COVID-19 Vaccine Era
2021, Brain Research BulletinAn emulated target trial analysis based on Medicare data suggested non-inferiority of Dabigatran versus Rivaroxaban
2021, Journal of Clinical Epidemiology
- 1
Present address: Michigan State University, College of Human Medicine, Division of Public Health, 130 E 2nd Street, Flint, MI 48502, United States.